Copyright Reports & Markets. All rights reserved.

USA Hospital-acquired Disease Testing Market Report 2018

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Hospital-acquired Disease Testing Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Type I Market Performance (Volume)
      • 2.1.2 Type II Market Performance (Volume)
    • 2.2 Overall Market Performance(Value)
      • 2.1.1 Type I Market Performance (Value)
      • 2.1.2 Type II Market Performance (Value)

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Application 1 Market Performance (Volume)
      • 3.1.2 Application 2 Market Performance (Volume)

    4 Manufacturers Profiles/Analysis

    • 4.1 Abbott Laboratories
      • 4.1.1 Abbott Laboratories Profiles
      • 4.1.2 Abbott Laboratories Product Information
      • 4.1.3 Abbott Laboratories Hospital-acquired Disease Testing Business Performance
      • 4.1.4 Abbott Laboratories Hospital-acquired Disease Testing Business Development and Market Status
    • 4.2 Becton and Dickenson
      • 4.2.1 Becton and Dickenson Profiles
      • 4.2.2 Becton and Dickenson Product Information
      • 4.2.3 Becton and Dickenson Hospital-acquired Disease Testing Business Performance
      • 4.2.4 Becton and Dickenson Hospital-acquired Disease Testing Business Development and Market Status
    • 4.3 BioMerieux
      • 4.3.1 BioMerieux Profiles
      • 4.3.2 BioMerieux Product Information
      • 4.3.3 BioMerieux Hospital-acquired Disease Testing Business Performance
      • 4.3.4 BioMerieux Hospital-acquired Disease Testing Business Development and Market Status
    • 4.4 Roche Diagnostics
      • 4.4.1 Roche Diagnostics Profiles
      • 4.4.2 Roche Diagnostics Product Information
      • 4.4.3 Roche Diagnostics Hospital-acquired Disease Testing Business Performance
      • 4.4.4 Roche Diagnostics Hospital-acquired Disease Testing Business Development and Market Status
    • 4.5 Akers Biosciences
      • 4.5.1 Akers Biosciences Profiles
      • 4.5.2 Akers Biosciences Product Information
      • 4.5.3 Akers Biosciences Hospital-acquired Disease Testing Business Performance
      • 4.5.4 Akers Biosciences Hospital-acquired Disease Testing Business Development and Market Status
    • 4.6 Alere
      • 4.6.1 Alere Profiles
      • 4.6.2 Alere Product Information
      • 4.6.3 Alere Hospital-acquired Disease Testing Business Performance
      • 4.6.4 Alere Hospital-acquired Disease Testing Business Development and Market Status
    • 4.7 Beckman Coulter/Danaher
      • 4.7.1 Beckman Coulter/Danaher Profiles
      • 4.7.2 Beckman Coulter/Danaher Product Information
      • 4.7.3 Beckman Coulter/Danaher Hospital-acquired Disease Testing Business Performance
      • 4.7.4 Beckman Coulter/Danaher Hospital-acquired Disease Testing Business Development and Market Status
    • 4.8 Cantel Medical
      • 4.8.1 Cantel Medical Profiles
      • 4.8.2 Cantel Medical Product Information
      • 4.8.3 Cantel Medical Hospital-acquired Disease Testing Business Performance
      • 4.8.4 Cantel Medical Hospital-acquired Disease Testing Business Development and Market Status
    • 4.9 Cepheid
      • 4.9.1 Cepheid Profiles
      • 4.9.2 Cepheid Product Information
      • 4.9.3 Cepheid Hospital-acquired Disease Testing Business Performance
      • 4.9.4 Cepheid Hospital-acquired Disease Testing Business Development and Market Status
    • 4.10 Diatherix Laboratories
      • 4.10.1 Diatherix Laboratories Profiles
      • 4.10.2 Diatherix Laboratories Product Information
      • 4.10.3 Diatherix Laboratories Hospital-acquired Disease Testing Business Performance
      • 4.10.4 Diatherix Laboratories Hospital-acquired Disease Testing Business Development and Market Status
    • 4.11 Eiken Chemical
    • 4.12 Enzo Biochem
    • 4.13 BioMerieux
    • 4.14 Roche Diagnostics
    • 4.15 Akers Biosciences

    5 Market Performance for Manufacturers

    • 5.1 USA Hospital-acquired Disease Testing Sales (K Units) and Market Share by Manufacturers 2013-2018
    • 5.2 USA Hospital-acquired Disease Testing Revenue (M USD) and Market Share by Manufacturers 2013-2018
    • 5.3 USA Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
    • 5.4 USA Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 Northeast Market Performance for Manufacturers
      • 6.1.1 Northeast Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.1.2 Northeast Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.1.3 Northeast Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
      • 6.1.4 Northeast Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
      • 6.1.5 Market Concentration
    • 6.2 Midwest Market Performance for Manufacturers
      • 6.2.1 Midwest Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.2.2 Midwest Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.2.3 Midwest Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
      • 6.2.4 Midwest Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
      • 6.2.5 Market Concentration
    • 6.3 South Market Performance for Manufacturers
      • 6.3.1 South Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.3.2 South Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.3.3 South Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
      • 6.3.4 South Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
      • 6.3.5 Market Concentration
    • 6.4 West Market Performance for Manufacturers
      • 6.4.1 West Hospital-acquired Disease Testing Sales (K Units) and Share of Manufacturers 2013-2018
      • 6.4.2 West Hospital-acquired Disease Testing Revenue (M USD) and Share of Manufacturers 2013-2018
      • 6.4.3 West Hospital-acquired Disease Testing Price (USD/Unit) of Manufacturers 2013-2018
      • 6.4.4 West Hospital-acquired Disease Testing Gross Margin of Manufacturers 2013-2018
      • 6.4.5 Market Concentration

    7 USA Hospital-acquired Disease Testing Market Performance (Sales Point)

    • 7.1 USA Hospital-acquired Disease Testing Sales (K Units) and Market Share by Regions 2013-2018
    • 7.2 USA Hospital-acquired Disease Testing Revenue (M USD) and Market Share by Regions 2013-2018
    • 7.3 USA Hospital-acquired Disease Testing Price (USD/Unit) by Regions 2013-2018
    • 7.4 USA Hospital-acquired Disease Testing Gross Margin by Regions 2013-2018

    8 Development Trend for Regions (Sales Point)

    • 8.1 USA Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.2 Northeast Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.3 Midwest Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.4 South Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018
    • 8.5 West Hospital-acquired Disease Testing Sales and Growth, Sales Value and Growth Rate2013-2018

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Application 1 Industry
    • 11.2 Application 2 Industry

    12 Market Forecast 2019-2024

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024
      • 12.1.1 USA Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024
      • 12.1.2 USA Hospital-acquired Disease Testing Sales (K Units) and Growth Rate 2019-2024
      • 12.1.3 Northeast Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.4 Midwest Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.5 South Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.6 West Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.7 Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.8 Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.9 Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.1.10 Hospital-acquired Disease Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.3 Sales (K Units), Revenue (M USD) by Types 2019-2024
      • 12.3.1 Overall Market Performance
      • 12.3.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
      • 12.3.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024
    • 12.4 Sales by Application 2019-2024
      • 12.4.1 Overall Market Performance
      • 12.4.2 Application 1 Sales and and Growth Rate 2019-2024
      • 12.4.3 Application 2 Sales and and Growth Rate 2019-2024
    • 12.5 Price (USD/Unit) and Gross Profit
      • 12.5.1 USA Hospital-acquired Disease Testing Price (USD/Unit) Trend 2019-2024
      • 12.5.2 USA Hospital-acquired Disease Testing Gross Profit Trend 2019-2024

    13 Conclusion

    Geographically, this report split USA into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Hospital-acquired Disease Testing for these regions, from 2012 to 2023 (forecast), including
    Northeast
    Midwest
    South
    West

    USA Hospital-acquired Disease Testing market competition by top manufacturers/players, with Hospital-acquired Disease Testing sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Abbott Laboratories
    Becton and Dickenson
    BioMerieux
    Roche Diagnostics
    Akers Biosciences
    Alere
    Beckman Coulter/Danaher
    Cantel Medical
    Cepheid
    Diatherix Laboratories
    Eiken Chemical
    Enzo Biochem
    Fujirebio/Innogenetics
    Gen-Probe
    Humor Diagnostica

    On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
    Type I
    Type II

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Hospital-acquired Disease Testing for each application, including
    Application 1
    Application 2

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now